Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

S010 - What's New and What's True in Lasers

Friday, February 16; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • 1. Define the newest techniques for dermatologic light based therapeutics.
  • 2. Evaluate drug/energy based device combinations for dermatologic indications.
  • 3. Describe limitations of current treatments and areas with research needs.

Description

What's New and What's True in Lasers will explore evaluation of new devices as well as innovative uses of devices that have been available. Speakers with both clinical and research experience will share their expertise on topics including: the newest vascular targeting devices, pearls for photorejuvenation using current technologies, device and drug combinations, light based treatments for basal cell carcinoma, laser treatment for onychomycosis, lasers for scar therapy, dermatologic devices adapted for women’s health and non-invasive fat removal. Novel cutting edge approaches will be highlighted and discussion will be encouraged.

Disclosures

  • Alexiades, Macrene, MD, PhD: Allergan, Inc – A(H); Alma Lasers – I(Grants/Research Funding); DEKA – I(Grants/Research Funding); DUSA Pharmaceuticals – I(Grants/Research Funding); Lancome – I(Grants/Research Funding); Syneron Candela – I(Grants/Research Funding);
  • Avram, Mathew M., MD, JD: Allergan, Inc – C(Fees); Cytrellis Biosystems, Inc – C(ST); Invasix – C(Fees); Masters of Aesthetics, Inc. – F(Fees); Merz Aesthetics – C(Fees); Sciton Inc. – A(Fees); Sienna Biopharmaceuticals – A(Fees); Zalea, LLC – C(Fees); Zeltiq Aesthetics – C(Fees);
  • Geronemus, Roy G., MD: Allergan, Inc – I(Grants/Research Funding); Allergan, Inc. – A(Grants/Research Funding); Cutera, Inc. – I(Grants/Research Funding); Cynosure, Inc – A(Grants/Research Funding), I(Grants/Research Funding); Cytrellis Biosystems, Inc – I(ST), SH(ST); Merz Aesthetics – I(Grants/Research Funding); Miramar Labs – I(Grants/Research Funding); Syneron Candela – A(Grants/Research Funding), I(Grants/Research Funding);
  • Kauvar, Arielle N.B., MD: Allergan, Inc – A(H); Lumenis – C(Fees); Sebcaia, Inc – C(Fees); Syneron, Inc. – I(Grants/Research Funding);
  • Kelly, Kristen Marie, MD: Allergan, Inc – C(H), I(Grants/Research Funding); Asclepion Laser Technologies GmbH – O(EQ); Candela Corporation – O(EQ), O(NC); Light Sciences Oncology – I(EQ); New Star Lasers – I(EQ); Reliant Technologies, Inc. – O(EQ); Thermage – O(EQ);
  • Kilmer, Suzanne L., MD: Allergan, Inc – I(Grants/Research Funding); Cutera, Inc. – I(Grants/Research Funding); Cynosure, Inc. – I(Grants/Research Funding); Cytrellis Biosystems, Inc – A(Grants/Research Funding); Galderma USA – A(H); Lumenis – I(Grants/Research Funding); Lutronics, Inc. – I(Grants/Research Funding); Merz Aesthetics – I(Grants/Research Funding); Miramar Labs – A(H); R2 Dermatology, Inc. – I(Grants/Research Funding); Sebacia, Inc. – I(Grants/Research Funding); Sienna Labs, Inc. – A(H); Solta Medical – I(Grants/Research Funding); Syneron Candela – A(Grants/Research Funding); Zarin Medical – A(H); Zeltiq Aesthetics – A(H); Zift Medical – A(H);
  • Nouri, Keyvan, MD: no financial relationships exist with commercial interests.
  • Ortiz, Arisa, MD: Alastin Skincare, Inc – C(H); Allergan, Inc – A(H), SH(NC), SP(H); BTL Industries – O(EQ); Cutera, Inc. – C(H); Guthy-Renker – SP(S); InMode MD Ltd – A(H), SP(H); Merz Aesthetics – A(H); Revance Therapeutics, Inc. – I(Grants/Research Funding); Rodan and Fields – A(H); Sciton Inc. – A(H), SP(H); Sienna Biopharmaceuticals – I(Grants/Research Funding); Ulthera – Data Safety Monitoring Board(H);
  • Waibel, Jill S., MD: Alma Lasers – SP(H); Aquavit Pharmaceuticals – I(SO); Candela Corporation – SP(H); Cutera, Inc. – I(Grants/Research Funding); Lumenis – I(H); Lutronics, Inc. – I(Grants/Research Funding); Michelson Diagnostics Ltd. – I(EQ); Regenx – C(Grants/Research Funding); Sciton Inc. – I(Grants/Research Funding); Sebacia, Inc. – I(Grants/Research Funding); Vivosight – I(Grants/Research Funding); Zeltiq Aesthetics – SP(H);
Schedule
Friday, February 16
1:00 PM
Dr. Kauvar / Devices and Skin the next generation
1:20 PM
Dr. Geronemus / Vascular Update
1:45 PM
Dr. Kilmer / Laser Treatment Pearls For Rejuvenation
2:05 PM
Dr. Kelly / Device and Drug Combinations
2:25 PM
Dr. Ortiz / Laser Treatment of Basal Cell Carcinoma – incorporating into your clinical practice
2:45 PM
Dr. Nouri / Lasers for Onychomycosis
3:00 PM
Dr. Waibel / Update on lasers for scars and assisted drug delivery
3:20 PM
Dr. Alexiades / Dermatologic Devices Adapted for Women’s Health
3:35 PM
Dr. Avram / Energy based devices for noninvasive fat removal: What’s New
3:45 PM
All faculty / Panel Discussion
Event Details
  • Date
    Friday, February 16
  • Time
    1:00 PM - 4:00 PM
  • Location
    Room 26A
  • CME Credits
    3.00
  • Type
    Restricted
Directors/Co-Directors
  • Kristen Marie Kelly, MD, FAAD - Handout
Speakers
  • Arielle N.B. Kauvar, MD, FAAD
  • Arisa Ortiz, MD, FAAD - Handout
  • Jill S. Waibel, MD, FAAD
  • Keyvan Nouri, MD, FAAD - Handout
  • Macrene Alexiades, MD, PhD, FAAD
  • Mathew M. Avram, MD, JD, FAAD
  • Roy G. Geronemus, MD, FAAD
  • Suzanne L. Kilmer, MD, FAAD - Handout